Boston Scientific Earlier Disclosed That On Apr. 3, Co. And Axonics Received Request For Additional Information From FTC In Connection With FTC's Merger Review; Says The Merger Is Now Expected To Be Completed In The Second Half Of 2024
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific and Axonics received a request for additional information from the FTC regarding their merger review, delaying the expected completion to the second half of 2024.
April 04, 2024 | 12:55 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Axonics' merger with Boston Scientific is delayed to H2 2024 due to an FTC request for additional information.
The FTC's request for additional information and the subsequent delay in the merger completion could create uncertainty, likely impacting Axonics' stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Boston Scientific's merger with Axonics is delayed due to an FTC inquiry, now expected to close in H2 2024.
The delay in the merger due to regulatory scrutiny could lead to uncertainty among investors, potentially affecting Boston Scientific's stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80